Akiko Hisamoto

Author PubWeight™ 10.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer. Lung Cancer 2004 1.39
2 Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review. PLoS One 2011 1.26
3 Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Lung Cancer 2007 0.96
4 Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells. Mol Cancer Res 2012 0.89
5 Phase II study of Amrubicin combined with carboplatin for thymic carcinoma and invasive thymoma: North Japan Lung Cancer group study 0803. J Thorac Oncol 2014 0.83
6 Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response. Lung Cancer 2012 0.81
7 Treatment-related death in patients with small-cell lung cancer in phase III trials over the last two decades. PLoS One 2012 0.80
8 Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation. Oncol Rep 2007 0.80
9 A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer 2004 0.78
10 Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells. Oncol Rep 2007 0.77
11 Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment. Anticancer Res 2009 0.77
12 Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation. Onco Targets Ther 2013 0.75
13 [Case report: Two cases of adult Langerhans cell histiocytosis treated with systemic chemotherapy]. Nihon Naika Gakkai Zasshi 2012 0.75
14 A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome. Intern Med 2013 0.75